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Abstract
Objective: To investigate the incidence of pelvic and paraaortic
lymph node metastasis in epithelial ovarian cancer.
Methods: This was a cross-sectional study. Data were collected
from medical records, and from the cancer registry 1539 medical
records were obtained. From there, 863 patients were operated
and 676 were not, and only 401 medical records were found
complete, and 306 samples were excluded because they have been
treated with NAC and underwent surgery, patients who underwent
surgery but the results is not the epithelium, and patients who
underwent surgery, but the results were benign or borderline. And
95 patients who underwent primary surgery and lymphadenectomy
only 55 patients have results in lymphadenectomy. This study uses
a calculation of sample size with categorial descriptions, with
precision of 3% then obtained a minimum sample size of 261
patients.
Results: According to the characteristics of the study subjects
above, the results were stage I, II, III respectively 60%, 10.9%, and
29%. The metastasized of the lymph node paraaortic 9.1%, and
pelvic/paraaortic 20% pelvic/paraaortic23.6%. Based on the
degree of differentiation the results were good differentiation
30.9%, moderate differentiation 23.6%, and poor differentiation
45.5%. We found that paraaortic lymph node metastasis were
most frequent at stadium III (43.8%). In relationship between
lymph node metastasis with differentiation of epithelial ovarian
cancer, the most frequent epithelial ovarian cancer were one with
poor differentiation in pelvic/paraaortic lymph node with the sum
of 69.2%. From analysis, there is significant difference between
serous hystologic subtype with mucinosum subtype in pelvic
lymph node, significant difference between serous hystologic
subtype and clear cell in paraorta or pelvic lymph node and
between the serous histology subtype and mucinous as well.
Conclusion: Lymph node metastasis incident of ovarian epithelial
cancer in paraaorta amounts 20%, pelvic 9.1% and pelvic or
paraaortic 23.6%. Higher the stadium, the lymph node involve-
ments will be higher as well (pelvic and paraaortic). In stadium 1
of mucinous subtype with well differentiation has minimal lymph
node involvement so we can be more selective in considering the
risk and benefit of lymphadenectomy.
[Indones J Obstet Gynecol 2018; 6-1: 60-63]
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Abstrak
Tujuan: Mengetahui insiden metastasis kanker ovarium epitelial
yang dilakukan pembedahan primer pada kelenjar getah beningpelvik, paraaorta dan pelvik/paraaorta di Rumah Sakit Dr. Cipto
Mangunkusumo periode Januari 2009 - Desember 2015.
Metode: Penelitian ini menggunakan desain penelitian potong
lintang, data diambil dari rekam medis, dari data kanker register
didapatkan 1584 daftar rekam medik, namun didapatkan 425pasien kanker ovarium, dan 331 yang ekslusi, didapatkan 55
data yang masuk kriteria inklusi.
Hasil: Dari 55 sampel yang dilakukan pembedahan primer pada
kanker ovarium tipe epitel. Penyebaran kelenjar getah bening padakanker epitel ovarium yang dilakukan pembedahan primer pada
KGB paraaorta adalah 20%, pelvik 9,1% dan pelvik/paraaorta
23,6%.
Kesimpulan: Insiden metastasis KGB kanker epitel ovarium padaparaaorta sebanyak 20%, pelvik 9,1% dan pada pelvik/paraaorta
23,6%. Semakin tinggi stadium, maka semakin tinggi keterlibatan
KGB (pelvik dan paraaorta). Pada subtipe serosum lebih banyakmenyebabkan keterlibatan pada KGB (pelvik dan paraaorta).
Semakin buruk derajat differensiasinya, maka semakin tinggi
keterlibatan pada KGB (paraaorta). Pada stadium I subtipemusinosum derajat difensiasi baik dengan keterlibatan pada KGB
yang minimal sehingga dapat lebih selektif dalam mempertim-bangkan risk dan benefit dari limfedenektomi.
[Maj Obstet Ginekol Indones 2018; 6-1: 60-63]
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INTRODUCTION
Ovarian cancer is one of the most common gyne-
cological cancers, after cervical and breast cancers.
Ovarian cancer metastasized directly through
extention and exfoliation, lymphatic and hemato-
genous.1,2 Stage, cell types, and tumor histological
differentiation influence the metastasis of ovarian
cancer.3 Lymphogenic metastasis most commonly
found in retroperitoneal pelvic and paraaortic
lymph nodes. Lymphogenic spread affects ovarian
cancer prognosis.1,4
Lymphadenectomy in ovarian cancer is still a
controversy.3,5 Currently, there is no profound
prospective study or randomized controlled trial
(RCT) regarding its pathological anatomy, leading
to this controversy. 1998 FIGO suggested that
pelvic and paraaortic lymphadenectomy are an
integrated part that could not be separated during
ovarian cancer surgical staging.6 Studies regarding
lymphadenectomy are not profound enough. To
date, there are no study published about the
incidence of epithelial ovarian cancer lymph node
metastasis at Dr. Cipto Mangunkusumo Hospital.
METHODS 
This was a cross-sectional study. Data were
collected from medical records, and the cancer
registry. Of these, 863 patients underwent primary
surgery and 676 were not, and only 401 medical
records were found complete, and 306 samples
were excluded because they have been treated
with NAC and underwent surgery, patients who
underwent surgery but the results is not the
epithelium, and patients who underwent surgery,
but the results are benign or borderline. And 95
patients who underwent primary surgery and
lymphadenectomy only 55 patients have results in
lymphadenectomy. This study uses a calculation of
sample size with categorial descriptions, with
precision of 3% then obtained a minimum sample
size of 261 patients.
RESULTS
1539 medical records were obtained. According to
the characteristics of the study subjects above, the
results are Stage I, II, III respectively 60%, 10.9%,
and 29%. The metastasized of the lymph node
paraaortic 9.1%, and pelvic/paraaortic 20%
pelvic/paraaortic 23.6%. Based on the degree of
differentiation the results were good differentia-
tion 30.9%, moderate differentiation 23.6%, and
poor differentiation 45.5%.
Table 1. Sample Characteristics patien of Epithelial
Ovarian Cancer Underwent Primary Surgery
Category n Percentage
Age :
<30 1 1.8
31-40 11 20
41-50 23 41.8
>51 20 36.4
Clinical stadium :
I 33 60
II 6 10.9
III 16 29.1
Lymph node metastasis :
Pelvic 5 9.1
Paraaortic 11 20
Pelvic/paraaortic 13 23.6
Negative 42 76.4
Grade :
NA 6 10.9
Well 16 29
Moderate 11 20
Poor 22 27.2
Histologisubtype :
Brenner 1 1.8
Clear cell 23 41.8
Endometioid 13 23.6
Mucinous 11 20
Serous 7 12.7
The association between lymph nodes metas-
tasis and cancer stadium are shown in Table 2.
We found that paraaortic lymph node metastasis
were most frequent at stadium III (43.8%) and the
least frequent at stadium II (0%). From the statis-
tical analysis we found significant difference in
proportion value in pelvic, paraaortic and pelvic/
paraaortic lymph node with higher value in
stadium III than stadium I (p<0.05).
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In relationship between lymph node metastasis
with differentiation of epithelial ovarian cancer, the
most frequent epithelial ovarian cancer were one
with poor differentiation in pelvic/paraaortic
lymph node with the sum of 69.2% and the least
frequent were one well differentiated in pelvic
lymph node (0%). From analysis, this study found
significant difference in proportion value in
paraaortic lymph node between those with poor
differentiation compared with moderate
differentiation, with p<0.05.
The most common incidence between lymph
node metastasis with histologic subtype were
shown in Table 2. Paraortic lymph node with
branner histologic type amounts1 100% because
the total of the samples in brenner is only 1, and
the second most common is serous hystologic in
paraaortic lymph nodes which is 42.9% and the
least is mucinosum subtype in pelvic lymph node,
amounted to 0%. There was significant difference
between serous hystologic subtype with
mucinosum subtype in pelvic lymph node,
significant difference between serous hystologic
subtype and clear cell in paraorta or pelvic lymph
node, and between the serous histology subtype
and mucinous as well.
Table 2. Distribution of Pelvic, Paraaortic, and Pelvic/Paraaortic Lymph Node Metastasis in Epithelial Ovarian Cancer
Clinical stadium Stadium In=33 Stadium IIn=6 Stadium IIIn=16 I vs II I vs III II vs III
Lymph node n % n % n % p value
Pelvic
 Positive 1 3 0 0 4 25 0.806 0.012* 0.064
 Negative 32 97.0 6 100 12 75
Paraaorta
 Positive 3 9.1 2 33.3 6 37.5 0.165 0.020* 0.823
 Negative 30 90.9 4 66.7 10 62.5
Pelvic/Paraaorta
 Positive 4 12.1 2 33.3 7 43.8 0.250 0.015* 0.599
 Negative 29 87.9 4 66.7 9 56.2
Table 3. Distribution of the Histological Subtypes of Pelvic, Paraaortic, and Pelvic/Paraaortic Metastasis in Epithelial
Ovarian Cancer
Histology Clear celln=23
Endometriosis
n=13
Brenner
n=1
Serous
n=7
Mucinous
n=11
Total
n=55
Lymph node n % n % n % n % n % n %
Pelvic
 Positive 2 8.7 1 7.7 0 0 2 28.6 0 0 5 9.1
 Negative 21 91.3 12 92.3 1 100 5 71.4 11 100 50 90.9
Paraaortic
 Positive 4 15.4 2 15.4 1 100 3 42.9 1 9.1 11 20.0
 Negative 19 84.6 11 84.6 0 0 4 57.1 10 90.9 44 80.0
Pelvic/Paraaortic
 Positive 4 17.4 2 15.4 1 100 3 42.9 1 9.1 13 23.6
 Negative 19 82.6 11 84.6 0 0 4 57.1 10 90.9 42 76.4
*p value < 0.05 ANOVA test
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There were significant differences in the pelvic
lymph nodes obstained value higher proportion on
serous histological subtype compare with
mucinous type (p<0.05) were show in Table 5, and
there were significant differences in the pelvic/
paraaortic lymph node metastases between clear
cell histology subtype compared to serous, as well
as between serous and mucinous histology sub-
type. However there were no significant difference
in paraaorta lymph node.
DISCUSSION
In this study, we could not reach the minimum
sample. From data subject characteristics showed
that the spread of ovarian cancer by age at most
in the age group 41-50 years by 41.8% this is in
accordance with what was found in the literature
that increasing age is a major risk factor for
developing ovarian cancer, 50% of ovarian cancers
diagnosed at the age of 65 years1,7 The spread of
lymph nodes obtained 23.6%, and the most to the
lymph node paraaorta is 20% for deployment on
paraaorta through lymphatic channels to follow
along infudibulopelvikum ovarian vein and ended
up in lymph nodes as high paraaorta renal blood
vessels, according to the study.8,9 This is in line
with a review conducted in the Netherlands M.
Kleppe et al (2011) were obtained from 14 studies
that incident spread of lymph node on ovarian
epithelial cancer was 14.2% (range 6.1-29.6%)
where only the lymph node 7.1% and only 2.9
paraaortic % in the pelvic lymph nodes.3,10
CONCLUSIONS
The incidence of lymph node metastasis of ovarian
epithelial cancer in paraaorta amounts 20%, pelvic
9.1% and pelvic or paraaortic 23.6%. Higher the
stadium, the lymph node involvements will be
higher as well (pelvic and paraaortic). In serous
subtype, there is more incidents of lymph node
involvements (pelvic and paraaortic). If the
differentiation type is worse, there will be higher
rate of pelvic and paraaortic lymph node
involvement. In stadium 1 of mucinous subtype
with well differentiation has minimal lymph node
involvement so we can be more selective in
considering the risk and benefit of lymphadenec-
tomy. Further prospective studies are required to
investigate the metastatic factors to lymph node
more accurately.
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